Rawan Shraim

8PUBLICATIONS
77CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 19, 2026
Differential cytokine architecture in patients treated with CART19 versus CART22.

|Feb 11, 2026
CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemia.

Jason Xu, Michael McCoy, Zachary Martinez

|Aug 08, 2025
Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia.

Haley Newman, Shawn H R Lee, Petri Pölönen

|May 28, 2025
Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia.

Haley Newman, Shawn H R Lee, Petri Pölönen

|Mar 16, 2025
Single-cell panleukemia signatures of HSPC-like blasts predict drug response and clinical outcome.

Changya Chen, Jason Xu, Jonathan H Sussman

|Feb 11, 2025
ImmunoTar-integrative prioritization of cell surface targets for cancer immunotherapy.

Rawan Shraim, Brian Mooney, Karina L Conkrite

Pageof 2

Frequent Collaborators

5 joint publications

Caroline Diorio

4 joint publications

Jonathan Sussman

4 joint publications

Lahari Uppuluri

4 joint publications

Haley Newman